Depression without psychotic symptoms. Severe depressive episode without psychotic symptoms
Conditions
Interventions
Intervention 1: In Placebo group, treatment includes venlafaxine 37.5 mg daily routine and oneT-Bag placebo (peppermint) every 12 hours (1/5 g). Intervention 2: In the case group, treatment includes v
Placebo
Treatment - Drugs
In Placebo group, treatment includes venlafaxine 37.5 mg daily routine and oneT-Bag placebo (peppermint) every 12 hours (1/5 g)
In the case group, treatment includes venlafaxine 37.5 mg daily routine every 12 hours one lavender teabag (1/5 g)
Routine treatment, daily 37.5 mg of venlafaxine
Sponsors
Shahrekord, Medical Sciences University Of
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients referring to psychiatric clinic of Shahrekord University of Medical Sciences; depression diagnosed by a psychiatrist for the first time. Exclusion criteria: being sensitive to lavender; history of previous use of antidepressants or antidepressant properties of lavender or plants; patients with psychosis and diabetes.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: Before the intervention, three weeks after the start of intervention and six weeks after the intervention. Method of measurement: Hamilton Depression and Anxiety Inventory.;Anxiety. Timepoint: Before the intervention, three weeks after the start of intervention and six weeks after the intervention. Method of measurement: Hamilton Depression and Anxiety Inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: 3 and 6 weeks after the intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDoctor Masoud Nikfarjam
Hajar Hospital
Outcome results
None listed